سعر جلوبيزولون 500 مجم مسحوق فيال للحقن الوريدي/العضلي 2026

Methylprednisolone sodium succinate 500 mg lyophilized powder vial for IV/IM use; Global Pharmaceutical Industries (Egypt).

• Corticosteroid for IM or IV use when oral therapy not feasible; indications include endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, and edematous states as listed on Solu-Medrol labeling.Population: AdultsDailyMed (U.S. NLM)

• Adverse effects of systemic corticosteroids include fluid retention, hypertension, muscle weakness, osteoporosis, peptic ulcer, impaired wound healing, and endocrine disturbances.International label, same formulation · DailyMed (U.S. NLM)

• Systemic fungal infections (unless needed to control drug reactions); known hypersensitivity to the product; intrathecal administration; and (for some formulations) use in premature infants depending on diluent—consult the specific vial labeling.International label, same formulation · DailyMed (U.S. NLM)

• May cause hypothalamic-pituitary-adrenal suppression, increased infection risk, elevated blood pressure, hyperglycemia, psychiatric effects, osteoporosis with prolonged use; do not stop abruptly after long-term therapy.International label, same formulation · DailyMed (U.S. NLM)

• Corticosteroids cross the placenta; use during pregnancy only if potential benefit justifies potential risk to the fetus; neonates of mothers receiving substantial doses should be observed for hypoadrenalism.International label, same formulation · DailyMed (U.S. NLM)

• Methylprednisolone sodium succinate: Synthetic glucocorticoid; binds cytoplasmic receptors and modulates gene transcription affecting inflammation and immune response.